Scientists have discovered that the drug losartan, commonly prescribed for high blood pressure, boosts brown adipose tissue activity in mice, enhancing their metabolism. This indicates that repurposing losartan—an angiotensin receptor blocker (ARB) with a well-known safety profile—may be a clinically viable method of stimulating brown fat, which has been linked to improved cardiovascular health and, reported for the first time in this study, psychiatric health.
🛡️
Just a quick checkWe’re checking your connection to prevent automated abuse
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Ученые нашли лекарство от давления, которое разбудило в теле жир, сжигающий калории | 0 | 5.72 | 16-10-2026 |
| 2 | Popular diabetes drug shown to lower inflammation, which may protect the heart | 0 | 11.73 | 06-10-2026 |
| 3 | Statins and blood pressure drugs changing health risks of obesity, study suggests | 0 | 7 | 01-07-2026 |
| 4 | Experimental compound helps burn fat without muscle loss | 0 | 8.8 | 23-08-2026 |
| 5 | After weight loss, exercise beats weight-loss drugs for heart health | 0 | 9.66 | 21-07-2026 |
| 6 | After weight loss, exercise improves cardiovascular health more than weight-loss medication | 2 | 6 | 08-07-2026 |
| 7 | Therapies to lower BP, lipids close gap in obesity-related CVD | 0 | 7 | 06-07-2026 |
| 8 | Statins helping people with obesity match those of healthy weight on key metrics, study finds | 0 | 7 | 02-07-2026 |
| 9 | Heart risk markers in adults over 40 with obesity increasingly converge with normal BMI levels | 0 | 7 | 01-07-2026 |
| 10 | Langzeitstudie zu Adipositas: Medikamente gleichen Herzrisiken an | 0 | 9.3 | 02-07-2026 |